LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Midwest Orthopaedics at Rush Opens Spine Tumor Center
Spine

Midwest Orthopaedics at Rush Opens Spine Tumor Center

April 4, 2016 1 min read Premium comments

Advertisement

Midwest Orthopaedics at Rush Opens Spine Tumor Center
Matthew W. Colman, M.D. / Courtesy of Midwest Orthopaedics at Rush
Secondary

Midwest Orthopaedics at Rush (MOR) has swung opened the doors to its newest endeavor, the Rush Spine Tumor Center. Leading this effort is Matthew W. Colman, M.D., Chicago’s only physician to have completed fellowships in both musculoskeletal oncology and spine surgery.

Howard An, M.D., Medical Director of Midwest Orthopaedics at Rush, stated in the March 23, 2016 news release, “We are thrilled to announce the opening of the Midwest Orthopaedics at Rush Spine Tumor Center, a place where patients facing a formidable challenge will receive care of the highest caliber. Dr. Colman goes to great lengths to make certain that his patients are armed with the latest information and treatments. They are in superb, caring hands.”

As indicated in the news release, “Dr. Colman obtained his medical degree from the University of Chicago Pritzker School of Medicine and an orthopedic surgery residency at the University of Pittsburgh. He undertook a fellowship in pediatric and adult musculoskeletal oncology at Harvard University and sought out further training as a fellow in orthopedic and neurosurgical spine surgery at the University of Utah.”

“There are many types of spine tumors, ” said Dr. Colman. “Some are cancerous and require a multidimensional approach involving radiation therapy and maybe even surgery. But many patients are surprised when I tell them their tumor may be benign and we can monitor it over time or treat it in a minimally invasive way.”

Dr. Colman told OTW, “My vision for the tumor center is that we leverage our world class capabilities in surgical, medical, and radiation oncology to become the national and international ‘go-to’ center for spine oncology.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy